巴布亚新几内亚疟疾知识的研究挑战和差距。
Research challenges and gaps in malaria knowledge in Papua New Guinea.
机构信息
Center for Global Health & Diseases, Case Western Reserve University, School of Medicine, Cleveland, OH 44106-7286, USA.
出版信息
Acta Trop. 2012 Mar;121(3):274-80. doi: 10.1016/j.actatropica.2011.08.002. Epub 2011 Aug 27.
Abstract
Taking into consideration the relative number of people living in Papua New Guinea the burden of malaria in this country is among the highest in Asia and the Pacific region. This article summarizes the research questions and challenges being undertaken by the Southwest Pacific International Center of Excellence for Malaria Research in the context of the epidemiology, transmission and pathogenesis of Plasmodium falciparum and P. vivax at the present time and the recent past. It is hoped that the research accomplished and local infrastructure strengthened by this effort will help inform regional and national policy with regard to the control and ultimately elimination of malaria in this region of the world.
摘要
考虑到巴布亚新几内亚的人口相对数量，该国的疟疾负担在亚洲和太平洋地区属于最高之列。本文总结了目前和最近一段时间，西南太平洋疟疾卓越研究中心在恶性疟原虫和间日疟原虫的流行病学、传播和发病机制方面所进行的研究问题和挑战。希望通过这一努力完成的研究工作和加强的地方基础设施，将有助于为该地区的疟疾控制和最终消除提供区域和国家政策方面的信息。
相似文献
1
Research challenges and gaps in malaria knowledge in Papua New Guinea.
Acta Trop. 2012 Mar;121(3):274-80. doi: 10.1016/j.actatropica.2011.08.002. Epub 2011 Aug 27.
2
Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.
Clin Microbiol Rev. 2011 Apr;24(2):377-410. doi: 10.1128/CMR.00051-10.
3
Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.
J Infect Dis. 2011 Apr 15;203(8):1192-1199. doi: 10.1093/infdis/jiq166.
4
The risk of malarial infections and disease in Papua New Guinean children.
Am J Trop Med Hyg. 2007 Jun;76(6):997-1008.
5
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Am J Trop Med Hyg. 2007 Nov;77(5):947-54.
6
The population structure of Plasmodium falciparum and Plasmodium vivax during an epidemic of malaria in the Eastern Highlands of Papua New Guinea.
Am J Trop Med Hyg. 2002 Nov;67(5):459-64. doi: 10.4269/ajtmh.2002.67.459.
7
Malaria Elimination: Time to Target All Species.
Am J Trop Med Hyg. 2018 Jul;99(1):17-23. doi: 10.4269/ajtmh.17-0869. Epub 2018 May 10.
8
The epidemiology of Plasmodium falciparum and Plasmodium vivax in East Sepik Province, Papua New Guinea, pre- and post-implementation of national malaria control efforts.
Malar J. 2020 Jun 5;19(1):198. doi: 10.1186/s12936-020-03265-x.
9
Vaccines against malaria: perspectives from Papua New Guinea.
Hum Vaccin. 2010 Jan;6(1):17-20. doi: 10.4161/hv.6.1.10332. Epub 2010 Jan 15.
10
Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea.
Malar J. 2015 Oct 9;14:399. doi: 10.1186/s12936-015-0879-9.
引用本文的文献
1
Vector composition, abundance, biting patterns and malaria transmission intensity in Madang, Papua New Guinea: assessment after 7 years of an LLIN-based malaria control programme.
Malar J. 2022 Jan 5;21(1):7. doi: 10.1186/s12936-021-04030-4.
2
The epidemiology of Plasmodium falciparum and Plasmodium vivax in East Sepik Province, Papua New Guinea, pre- and post-implementation of national malaria control efforts.
Malar J. 2020 Jun 5;19(1):198. doi: 10.1186/s12936-020-03265-x.
3
Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children.
BMC Med. 2019 Dec 9;17(1):220. doi: 10.1186/s12916-019-1456-9.
4
Health information system strengthening and malaria elimination in Papua New Guinea.
Malar J. 2017 Jul 5;16(1):278. doi: 10.1186/s12936-017-1910-0.
5
Higher Complexity of Infection and Genetic Diversity of Than Across All Malaria Transmission Zones of Papua New Guinea.
Am J Trop Med Hyg. 2017 Mar;96(3):630-641. doi: 10.4269/ajtmh.16-0716. Epub 2017 Apr 6.
6
Entomological Monitoring and Evaluation: Diverse Transmission Settings of ICEMR Projects Will Require Local and Regional Malaria Elimination Strategies.
Am J Trop Med Hyg. 2015 Sep;93(3 Suppl):28-41. doi: 10.4269/ajtmh.15-0009. Epub 2015 Aug 10.
7
Knowledge, attitudes, and practices concerning malaria in pregnancy: results from a qualitative study in Madang, Papua New Guinea.
PLoS One. 2015 Apr 20;10(4):e0119077. doi: 10.1371/journal.pone.0119077. eCollection 2015.
8
Plasmodium vivax populations are more genetically diverse and less structured than sympatric Plasmodium falciparum populations.
PLoS Negl Trop Dis. 2015 Apr 15;9(4):e0003634. doi: 10.1371/journal.pntd.0003634. eCollection 2015 Apr.
9
Whole-genome sequencing reveals absence of recent gene flow and separate demographic histories for Anopheles punctulatus mosquitoes in Papua New Guinea.
Mol Ecol. 2015 Mar;24(6):1263-74. doi: 10.1111/mec.13107. Epub 2015 Mar 6.
10
Quality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chain.
PLoS One. 2014 May 14;9(5):e96810. doi: 10.1371/journal.pone.0096810. eCollection 2014.
本文引用的文献
1
Characterization of treatment failure in efficacy trials of drugs against Plasmodium vivax by genotyping neutral and drug resistance-associated markers.
Antimicrob Agents Chemother. 2011 Sep;55(9):4479-81. doi: 10.1128/AAC.01552-10. Epub 2011 Jun 27.
2
Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia.
PLoS Negl Trop Dis. 2011 Jun;5(6):e1032. doi: 10.1371/journal.pntd.0001032. Epub 2011 Jun 7.
3
A research agenda for malaria eradication: diagnoses and diagnostics.
PLoS Med. 2011 Jan 25;8(1):e1000396. doi: 10.1371/journal.pmed.1000396.
4
A research agenda for malaria eradication: drugs.
PLoS Med. 2011 Jan 25;8(1):e1000402. doi: 10.1371/journal.pmed.1000402.
5
A research agenda for malaria eradication: cross-cutting issues for eradication.
PLoS Med. 2011 Jan 25;8(1):e1000404. doi: 10.1371/journal.pmed.1000404.
6
Critical interactions between Global Fund-supported programmes and health systems: a case study in Papua New Guinea.
Health Policy Plan. 2010 Nov;25 Suppl 1:i48-52. doi: 10.1093/heapol/czq058.
7
Minimal association of common red blood cell polymorphisms with Plasmodium falciparum infection and uncomplicated malaria in Papua New Guinean school children.
Am J Trop Med Hyg. 2010 Oct;83(4):828-33. doi: 10.4269/ajtmh.2010.09-0713.
8
Robert Koch redux: malaria immunology in Papua New Guinea.
Parasite Immunol. 2010 Aug;32(8):623-32. doi: 10.1111/j.1365-3024.2010.01238.x.
9
Population hemoglobin mean and anemia prevalence in Papua New Guinea: new metrics for defining malaria endemicity?
PLoS One. 2010 Feb 24;5(2):e9375. doi: 10.1371/journal.pone.0009375.
10
Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children.
PLoS One. 2010 Feb 4;5(2):e9047. doi: 10.1371/journal.pone.0009047.
Zotero 插件